Literature DB >> 29525823

Topical blood stopper agents during adenoid surgery in young children; a prospective randomized controlled trial.

Randa A Abdallah1,2, Sameh M Ragab3, Maher Z Hassanin4.   

Abstract

OBJECTIVE: To investigate the safety and efficacy of two topical blood stopper modulators; Ankaferd blood stopper (ABS) and feracrylum 1% solution (FS) during adenoid surgery. STUDY
DESIGN: Prospective randomized trial.
METHODS: Two hundred and twenty five consecutive pediatric adenoid patients aged from 9 months to 2 years old were studied. Patients were randomly allocated into two haemostatic groups; (ABS, FS) and normal saline (control group).
RESULTS: ABS and FS groups showed a significantly less intra operative blood loss (16.4 ± 2.6/22 ± 6.2), operative time (9.31 ± 1.9/11.2 ± 1.6 min), use of cautery (10.6/25.3%), postoperative analgesics (3 ± 1.1/3.8 ± 1.2), duration to return normal diet (2.4 ± 1.2/3.9 ± 0.9) and operating theatre cost (233 ± 48$ and 279 ± 40$) than the control group.
CONCLUSION: AFS and FS are easy, safe, and reliable topical haemostatic modulators that could be used in adenoid surgery.

Entities:  

Keywords:  Adenoidectomy; Ankaferd; Controlled; Feracylum; Haemostatic; Randomised; Topical

Mesh:

Substances:

Year:  2018        PMID: 29525823     DOI: 10.1007/s00405-018-4929-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

1.  An aberrant artery as a cause of massive bleeding following adenoidectomy.

Authors:  J P Windfuhr
Journal:  J Laryngol Otol       Date:  2002-04       Impact factor: 1.469

Review 2.  Electrocautery adenoidectomy compared with curettage and power-assisted methods.

Authors:  Ravindhra G Elluru; Liane Johnson; Charles M Myer
Journal:  Laryngoscope       Date:  2002-08       Impact factor: 3.325

3.  Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings.

Authors:  Martin A Schreiber; Deborah J Neveleff
Journal:  AORN J       Date:  2011-11       Impact factor: 0.676

4.  Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper.

Authors:  H Goker; I C Haznedaroglu; S Ercetin; S Kirazli; U Akman; Y Ozturk; H C Firat
Journal:  J Int Med Res       Date:  2008 Jan-Feb       Impact factor: 1.671

5.  The hemostatic efficacy of Ankaferd Blood Stopper in adenoidectomy.

Authors:  Ismail Iynen; Ferhat Bozkus; Imran San; Necat Alatas
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2011-08-02       Impact factor: 1.675

6.  Topical adrenaline in the control of intraoperative bleeding in adenoidectomy: a randomised, controlled trial.

Authors:  H Teppo; H Virkkunen; M Revonta
Journal:  Clin Otolaryngol       Date:  2006-08       Impact factor: 2.597

7.  A prospective comparison of topical feracrylum citrate versus adrenaline as haemostatic agent in hypospadias surgery in children.

Authors:  Ashok Kumar Laddha; Mazharkhan Mulla; Shashi Shankar Sharma; Brijesh Kumar Lahoti; Rajkumar Mathur
Journal:  Afr J Paediatr Surg       Date:  2014 Jul-Sep

8.  A prospective study on pros and cons of electrodissection tonsillectomy.

Authors:  K Blomgren; Y H Qvarnberg; H J Valtonen
Journal:  Laryngoscope       Date:  2001-03       Impact factor: 3.325

9.  Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy.

Authors:  Aysenur Meric Teker; Arzu Yasemin Korkut; Orhan Gedikli; Volkan Kahya
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-12       Impact factor: 1.675

10.  Complications of adenotonsillectomy in children with OSAS younger than 2 years of age.

Authors:  Youval Slovik; Asher Tal; Yoram Shapira; Ariel Tarasiuk; Alberto Leiberman
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-08       Impact factor: 1.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.